Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia

Neuroscience

Volumn 169, Issue 1, 2010, Pages 158-170

  Beyeler, A ^a,b   Kadiri, N ^a,b   Navailles, S ^a,b   Boujema, M B ^a,b   Gonon, F ^a,b   Moine, C L ^a,b   Gross, C ^a,b,c   De Deurwaerdere P ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UMR 5287   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

C Fos; Orofacial motor cortex; Ro 60 0175; SB 243213; Single cell extracellular recordings; Substantia nigra pars reticulata

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; PROTEIN C FOS; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROSTIMULATION; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; MALE; MOTOR CORTEX; NONHUMAN; NUCLEUS ACCUMBENS; OROFACIAL DYSKINESIA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR CORTEX; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; BASAL GANGLIA; DYSKINESIA, DRUG-INDUCED; ELECTRIC STIMULATION; ETHYLAMINES; FACIAL MUSCLES; GENE EXPRESSION REGULATION; GENES, FOS; INDOLES; MALE; MOUTH; NEURAL PATHWAYS; ONCOGENE PROTEINS V-FOS; PREFRONTAL CORTEX; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN RECEPTOR AGONISTS; SUBSTANTIA NIGRA;

EID: 77953806583     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.04.061     Document Type: Article

References (66)

1. Barwick V.S., Jones D.H., Richter J.T., Hicks P.B., Young K.A. Subthalamic nucleus microinjections of 5-HT2 receptor antagonists suppress stereotypy in rats. Neuroreport 2000, 11:267-270.
2. 2C receptor-mediated responses. J Pharmacol Exp Ther 2006, 319:260-268.
3. Bersani G., Grispini A., Marini S., Pasini A., Valducci M., Ciani N. Neuroleptic-induced extrapyramidal side effects: clinical perspective with Ritanserin (R 55667), a new selective 5-HT2 receptor blocking agent. Curr Ther Res 1986, 40:492-499.
4. Blomeley C., Bracci E. Excitatory effects of serotonin on rat striatal cholinergic interneurones. J Physiol 2005, 569:715-721.
5. Bubar M.J., Cunningham K.A. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog Brain Res 2008, 172:319-346.
6. Bunney B.S., Walters J.R., Roth R.H., Aghajanian G.K. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 1973, 185:560-571.
7. Carlson B.B., Wisniecki A., Salamone J.D. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor. Psychopharmacology (Berl) 2003, 165:229-237.
8. Carta M., Carlsson T., Kirik D., Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007, 130:1819-1833.
9. 2C receptor protein in the rat CNS. Neuropharmacology 2000, 39:123-132.
10. Daniel W.W. Biostatistics: a foundation for analysis in the health sciences 1974, John Wiley & Sons, Inc, Canada.
11. De Deurwaerdère P., Chesselet M.F. Nigrostriatal lesions alter orofacial dyskinesia and c-fos expression induced by the serotonin agonist 1-(m-cholophenyl) piperazine in adult rats. J Neurosci 2000, 20:5170-5178.
12. De Deurwaerdère P., Navailles S., Berg K.A., Clarke W.P., Spampinato U. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 2004, 24:3235-3241.
13. De Deurwaerdère P., Stinus L., Spampinato U. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J Neurosci 1998, 18:6528-6538.
14. Deniau J.M., Menetrey A., Charpier S. The lamellar organization of the rat substantia nigra pars reticulata: segregated patterns of striatal afferents and relationship to the topography of corticostriatal projections. Neuroscience 1996, 73:761-781.
15. Deniau J.M., Hammond C., Riszk A., Feger J. Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): evidences for the existence of branched neurons. Exp Brain Res 1978, 32:409-422.
16. Di Giovanni G., Di Matteo V., La Grutta V., Esposito E. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 2001, 103:111-116.
17. Di Matteo V., Pierucci M., Esposito E., Crescimanno G., Benigno A., Di Giovanni G. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog Brain Res 2008, 172:423-463.
18. 2C-induced oral dyskinesia. Neuroscience 1996, 72:117-128.
19. 2C receptor messenger RNA in the basal ganglia of adults rats. J Comp Neurol 1997, 384:233-247.
20. Filip M.M., Cunningham K.A. Serotonin 5-HT(2C) receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 2002, 71:745-756.
21. Fletcher P.J., Rizos Z., Sinyard J., Tampakeras M., Higgins G.A. The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 2008, 33:1402-1412.
22. Flores G., Rosales M.G., Hernández S., Sierra A., Aceves J. 5-Hydroxytryptamine increases spontaneous activity of subthalamic neurons in the rat. Neurosci Lett 1995, 192:17-20.
23. Georges F., Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 2002, 22:5173-5187.
24. Gong L., Kostrzewa R.M., Fuller R.W., Perry K.W. Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther 1992, 261:1000-1007.
25. Groenewegen H.J., Wright C.I., Beijer A.V. The nucleus accumbens: gateway for limbic structures to reach the motor system?. Prog Brain Res 1996, 107:485-511.
26. Grottick A.J., Fletcher P.J., Higgins G.A. Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 2000, 295:1183-1191.
27. Guigoni C., Li Q., Aubert I., Dovero S., Bioulac B.H., Bloch B., Crossman A.R., Gross C.E., Bezard E. Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci 2005, 25:2102-2107.
28. Gunes A., Dahl M.L., Spina E., Scordo M.G. Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients. Eur J Clin Pharmacol 2008, 64:477-482.
29. Hackler E.A., Turner G.H., Gresch P.J., Sengupta S., Deutch A.Y., Avison M.J., Gore J.C., Sanders-Bush E. 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. J Pharmacol Exp Ther 2007, 320:1023-1029.
30. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 1995, 47:133-178.
31. Ikeguchi K., Kuroda A. Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs. Eur Arch Psychiatry Clin Neurosci 1995, 244:320-324.
32. Ikram H., Samad N., Haleem D.J. Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia. Pak J Pharm Sci 2007, 20:188-195.
33. Invernizzi R.W., Pierucci M., Calcagno E., Di Giovanni G., Di Matteo V., Benigno A., Esposito E. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study. Neuroscience 2007, 144:1523-1535.
34. Jones B.J., Blackburn T.P. The medical benefit of 5-HT research. Pharmacol Biochem Behav 2002, 71:555-568.
35. Kolomiets B.P., Deniau J.M., Glowinski J., Thierry A.M. Basal ganglia and processing of cortical information: functional interactions between trans-striatal and trans-subthalamic circuits in the substantia nigra pars reticulata. Neuroscience 2003, 117:931-938.
36. 2C receptor antagonist treatment. Neurotox Res 2007, 11:41-50.
37. Kuan W.L., Zhao J.W., Barker R.A. The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. Psychopharmacology (Berl) 2008, 197:279-293.
38. Marchand W.R., Dilda V. New models of frontal-subcortical skeletomotor circuit pathology in tardive dyskinesia. Neuroscientist 2006, 12:186-198.
39. Marquis K.L., Sabb A.L., Logue S.F., Brennan J.A., Piesla M.J., Comery T.A., Grauer S.M., Ashby C.R., Nguyen H.Q., Dawson L.A., Barrett J.E., Stack G., Meltzer H.Y., Harrison B.L., Rosenzweig-Lipson S. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b] [1,4]diazepino [6,7,1hi] indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 2007, 320:486-496.
40. Martin J.R., Bös M., Jenck F., Moreau J., Mutel V., Sleight A.J., Wichmann J., Andrews J.S., Berendsen H.H., Broekkamp C.L., Ruigt G.S., Köhler C., Delft A.M. 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 1998, 286:913-924.
41. Maurice N., Deniau J.M., Glowinski J., Thierry A.M. Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits. J Neurosci 1999, 19:4674-4681.
42. Meltzer H.Y., Li Z., Kaneda Y., Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:1159-1172.
43. Parry T.J., Eberle-Wang K., Lucki I., Chesselet M.F. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp Neurol 1994, 128:181-190.
44. Pasqualetti M., Ori M., Castagna M., Marazziti D., Cassano G.B., Nardi I. Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience 1999, 92:601-611.
45. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA, USA. 4th ed.
46. Plech A., Brus R., Kalbfleisch J.H., Kostrzewa R.M. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CCP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesionned rats. Psychopharmacology (Berl) 1995, 119:466-473.
47. Prinssen E.P., Balestra W., Bemelmans F.F., Cools A.R. Evidence for a role of the shell of the nucleus accumbens in oral behavior of freely moving rats. J Neurosci 1994, 14:1555-1562.
48. Rick C.E., Stanford I.M., Lacey M.G. Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors. Neuroscience 1995, 69:903-913.
49. Rocha B.A., Goulding E.H., O'Dell L.E., Mead A.N., Coufal N.G., Parsons L.H., Tecott L.H. Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 2002, 22:10039-10045.
50. 2C receptor mutant mice. Naunyn Schmiedebergs Arch Pharmacol 2000, 361:484-491.
51. Ryan L.J., Sanders D.J. Subthalamic nucleus and globus pallidus lesions alter activity in nigrothalamic neurons in rats. Brain Res Bull 1994, 34:19-26.
52. Salamone J.D., Mayorga A.J., Trevitt J.T., Cousins M.S., Conlan A., Nawab A. Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol 1998, 56:591-611.
53. Sgambato V., Abo V., Rogard M., Besson M.J., Deniau J.M. Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 1997, 81:93-112.
54. 2C agonist elicits hyperactivity and oral dyskinesia with hypophagia in rabbits. Physiol Behav 2004, 82:97-107.
55. Singewald N., Salchner P., Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 2003, 53:275-283.
56. Soubrié P., Reisine T.D., Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience 1984, 13:605-625.
57. Stanford I.M., Kantaria M.A., Chahal H.S., Loucif K.C., Wilson C.L. 5-Hydroxytryptamine induced excitation and inhibition in the subthalamic nucleus: action at 5-HT(2C), 5-HT(4) and 5-HT(1A) receptors. Neuropharmacology 2005, 49:1228-1234.
58. 2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J Neurosci 1996, 16:7566-7573.
59. Stark J.A., Davies K.E., Williams S.R., Luckman S.M. Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine. Neuroimage 2006, 31:1228-1237.
60. Stark J.A., McKie S., Davies K.E., Williams S.R., Luckman S.M. 5-HT(2C) antagonism blocks blood oxygen level-dependent pharmacological-challenge magnetic resonance imaging signal in rat brain areas related to feeding. Eur J Neurosci 2008, 27:457-465.
61. Stewart B.R., Jenner P., Marsden C.D. Induction of purposeless chewing behavior in rats by 5-HT agonists drugs. Eur J Pharmacol 1989, 162:101-107.
62. Uchida T., Adachi K., Fujita S., Lee J., Gionhaku N., Cools A.R., Koshikawa N. Role of GABA(A) receptors in the retrorubral field and ventral pallidum in rat jaw movements elicited by dopaminergic stimulation of the nucleus accumbens shell. Eur J Pharmacol 2005, 510:39-47.
63. 2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapy. Psychopharmacology (Berl) 2005, 182:84-94.
64. Wood M.D., Reavill C., Trail B., Wilson A., Stean T., Kennett G.A., Lightowler S., Blackburn T.P., Thomas D., Gager T.L., Riley G., Holland V., Bromidge S.M., Forbes I.T., Middlemiss D.N. SB-243213: a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 2001, 41:186-199.
65. Xiang Z., Wang L., Kitai S.T. Modulation of spontaneous firing in rat subthalamic neurons by 5-HT receptor subtypes. J Neurophysiol 2005, 93:1145-1157.
66. Zhang Q.J., Liu X., Liu J., Wang S., Ali U., Wu Z.H., Wang T. Subthalamic neurons show increased firing to 5-HT2C receptor activation in 6-hydroxydopamine-lesioned rats. Brain Res 2009, 1256:180-189.